ZuriMED Technologies AG is an innovation-driven Swiss company based in Zurich that spun off in 2015 from the Institute for Biomechanics at ETH Zurich. ZuriMED excels as an innovation engine, driven by a dynamic management team and backed by a network of world-leading scientists, clinicians, and medical industry experts. ZuriMED’s strength lies in its ability to think outside the box and foster disruptive technologies that effectively tackle unmet clinical needs.
ZuriMED Secures FDA Clearance for its FiberLocker System (startupticker.ch)
Strong Swiss delegation at Medica Startup Park (startupticker.ch)
ZuriMED closes CHF 14.5 million series A financing round to revolutionize surgery with Surgical-Fiberlock technology (venturelab.swiss)
ZuriMED closes CHF 14.5 million Series A round (startupticker.ch)
Swiss Accelerator: Innosuisse supports 53 companies with CHF112 million (startupticker.ch)
ZuriMED obtains the Innosuisse Certificate (startupticker.ch)
Ten start-ups selected for the venture leaders China program (startupticker.ch)
Ten start-ups selected for the venture leaders China program (startupticker.ch)
18 startups selected for the Investor Summit 2017 (startupticker.ch)
20 Schweizer Startups zu Gast in München (startupticker.ch)
IMD announces the 25 startup competition winners (startupticker.ch)
ZuriMED überzeugt im Venture Kick Finale (startupticker.ch)
And the winners of >>venture>> 2015 are: CUTISS and Pregnostics (startupticker.ch)
The “Swiss National Startup Team” ready to conquer the USA (startupticker.ch)